Log in
Enquire now
‌

US Patent 10555931 Pharmaceutical combination for the treatment of cancer

Patent 10555931 was granted and assigned to Piramal Enterprises on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Piramal Enterprises
Piramal Enterprises
Current Assignee
Piramal Enterprises
Piramal Enterprises
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10555931
Patent Inventor Names
Owe Orwar0
Prabha Mishra0
Sreesha Srinivasa0
Date of Patent
February 11, 2020
Patent Application Number
15313543
Date Filed
May 27, 2015
Patent Citations Received
‌
US Patent 11925618 Pharmaceutical combination for the treatment of cancer
0
Patent Primary Examiner
‌
Blessing M Fubara
Patent abstract

The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10555931 Pharmaceutical combination for the treatment of cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us